Bryan Giraudo
2021
In 2021, Bryan Giraudo earned a total compensation of $2.8M as Chief Operating Officer and Financial Officer at Gossamer Bio, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,313 |
|---|---|
| Option Awards | $1,733,082 |
| Salary | $438,492 |
| Stock Awards | $440,550 |
| Other | $3,000 |
| Total | $2,825,437 |
Giraudo received $1.7M in option awards, accounting for 61% of the total pay in 2021.
Giraudo also received $210.3K in non-equity incentive plan, $438.5K in salary, $440.6K in stock awards and $3K in other compensation.
Rankings
In 2021, Bryan Giraudo's compensation ranked 4,661st out of 12,415 executives tracked by ExecPay. In other words, Giraudo earned more than 62.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,661 out of 12,415 | 63rd |
Division Manufacturing | 1,932 out of 5,505 | 65th |
Major group Chemicals And Allied Products | 808 out of 2,375 | 66th |
Industry group Drugs | 721 out of 2,096 | 66th |
Industry Pharmaceutical Preparations | 515 out of 1,546 | 67th |
Source: SEC filing on April 27, 2022.
Giraudo's colleagues
We found two more compensation records of executives who worked with Bryan Giraudo at Gossamer Bio in 2021.